Download PDF
Zeitschrift für Phytotherapie 2022; 42(05): 216-220
DOI: 10.1055/a-1874-9617
Praxis

Phytotherapeutika zur Behandlung von vasomotorischen Symptomen im Klimakterium

Susan Zeun
› Further Information
    Permissions and Reprints

Vasomotorische Symptome treten in der Peri- und Postmenopause auf und sind eines der Hauptsymptome der Wechseljahre, weshalb Frauen Hilfe suchen. Es gibt zahlreiche phytotherapeutische Möglichkeiten, diese Beschwerden zu behandeln. In Abhängigkeit von Begleitsymptomen (Unruhe, Schlaflosigkeit, depressive Verstimmungen) und dem zeitlichen Auftreten bzgl. des reproduktiven Zyklus der Betroffenen ist eine individuelle Behandlung möglich.



Publication History

Article published online:
24 October 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Avis NE, Crawford SL. et al. Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 1997; 3: 103-120
    PubMedGoogle Scholar
  • 2 Avis NE, Crawford SL, Greendale G. et al. Study of Women’s Health Across the Nation. Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition. JAMA Intern Med 2015; 175: 531-539
    CrossrefPubMedGoogle Scholar
  • 3 Deecher DC. Physiology of thermoregulatory dysfunction and current approaches to the treatment of vasomotor symptoms. Expert Opin Investig Drugs 2005; 14: 434-448
    CrossrefPubMedGoogle Scholar
  • 4 Szegila A, Czyzyz A. et al. The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications. Gynecol Endocrinol 2018; 34: 913-919
    CrossrefPubMedGoogle Scholar
  • 5 Dietz BM. et al. Botanicals and their bioactive phytochemicals for women’s health. Pharmacol Rev 2016; 68: 1026-1073
    CrossrefPubMedGoogle Scholar
  • 6 AWMF. S3-Leitlinienprogramm: Peri- und Postmenopause – Diagnostik und Interventionen. Im Internet: https://www.awmf.org/uploads/tx_szleitlinien/015-062l_S3_HT_Peri-Postmenopause-Diagnostik-Interventionen_2021-01.pdf Abruf 06.09.2022
    PubMed
  • 7 Schilcher H. Hrsg. Leitfaden Phytotherapie. 5. Aufl. München: Elsevier/Urban & Fischer; 2016: 63-64
    Google Scholar
  • 8 Bent S, Padula A. et al. Valerian for sleep: a systematic review and meta-analysis. Am J Med 2006; 119: 1005-1101
    CrossrefPubMedGoogle Scholar
  • 9 Semwal P, Painuli S. et al. Diosgenin: An updated pharmacological review and therapeutic perspective. Oxid Med Cell Longev 2022; 2022: 1035441
    CrossrefPubMedGoogle Scholar
  • 10 Greco S, Pellegrino P. et al. Phytoprogestins: unexplored food compounds with potential preventive and therapeutic effects in female diseases. Nutrients 2021; 13: 4326
    CrossrefPubMedGoogle Scholar
  • 11 Swaroop A, Jaipuriar AS, Gupta SK. et al. Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, Furocyst) in polycystic ovary syndrome (PCOS). Int J Med Sci 2015; 12: 825-831
    CrossrefPubMedGoogle Scholar
  • 12 Schilcher H. Hrsg. Leitfaden Phytotherapie. 5. Aufl. München: Elsevier/Urban & Fischer; 2016: 160-161
    Google Scholar
  • 13 Milligan SR, Kalita JC. et al. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J Clin Endocrinol Metab 1999; 84: 2249-2252
    CrossrefPubMedGoogle Scholar
  • 14 Aghamiri V, Mirghafourvand M. et al. The effect of hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: A randomized placebo-controlled trial. Complement Ther Clin Pract 2016; 23: 130-135
    CrossrefPubMedGoogle Scholar
  • 15 Kenda M, Glavac N. et al. Herbal products used in menopause and for gynecological disorders. Molecules 2021; 26: 7421
    Google Scholar
  • 16 Nanashima N, Horie K. et al. Phytoestrogenic activity of blackcurrant anthocyanins is partially mediated through estrogen receptor beta. Molecules 2017; 23: 74
    CrossrefPubMedGoogle Scholar
  • 17 Neary JT, Bu Y. Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res 1999; 816: 358-363
    CrossrefPubMedGoogle Scholar
  • 18 Eatemadnia A, Ansari S. et al. The effect of Hypericum perforatum on postmenopausal symptoms and depression: A randomized controlled trial. Complement Ther Med 2019; 45: 109-113
    CrossrefPubMedGoogle Scholar
  • 19 Dew TP, Williamson G. Controlled flax interventions for the improvement of menopausal symptoms and postmenopausal bone health: a systematic review. Menopause 2013; 20: 1207-1215
    CrossrefPubMedGoogle Scholar
  • 20 Colli M, Bracht A. et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. J Med Food 2012; 15: 840-845
    CrossrefPubMedGoogle Scholar
  • 21 Hoberg E, Orjala J. et al. Diterpenoids from the fruits of Vitex agnus-castus . Phytochemistry 1999; 52: 1555-1558 DOI: 10.1016/S0031-9422(99)00181-8.
    CrossrefPubMedGoogle Scholar
  • 22 Marjoribanks J, Brown J. et al. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2013; CD001396 DOI: 10.1002/14651858.CD001396.pub3.
    CrossrefPubMedGoogle Scholar
  • 23 Van Die MD, Burger HG. et al. Vitex agnus-castus (Chaste-tree/berry) in the treatment of menopause-related complaints. J Altern Complement Med 2009; 15: 853-862
    CrossrefPubMedGoogle Scholar
  • 24 Wober J, Möller F. et al. Activation of estrogen receptor-beta by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds. J Steroid Biochem Mol Biol 2007; 107: 191-201
    CrossrefPubMedGoogle Scholar
  • 25 Thomas AJ, Ismail R. et al. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review. Maturitas 2014; 78: 263-276
    CrossrefPubMedGoogle Scholar
  • 26 Mohsen A, Fatemeh K. et al. Pharmacological and therapeutic properties of the red clover (Trifolium pratense L.): an overview of the new findings. J Tradit Chin Med 2021; 41: 642-649
    PubMedGoogle Scholar
  • 27 Rahte S, Evans R. et al. Salvia officinalis for hot flushes: towards determination of mechanism of activity and active principles. Planta Med 2013; 79: 753-760 DOI: 10.1055/s-0032-1328552.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 European Medicines Agency. . European Union herbal monograph on Salvia officinalis L., folium. Im Internet: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-salvia-officinalis-l-folium-revision-1_en.pdf; Abruf 06.09.2022
    PubMed
  • 29 Smith T, Gillespie M, Eckl V. et al. Herbal supplement sales in US increase by 9.4% in 2018. Herbalgram 2019; 123: 62-73
    PubMedGoogle Scholar
  • 30 Jarry H, Gorkow C, Wuttke W. Treatment of Menopausal Symptoms with Extracts of Cimicifuga racemosa: In vivo and in vitro Evidence for Estrogenic Activity. In: Loew D, Rietbrock N, Hrsg. Phytopharmaka in Forschung und klinischer Anwendung. Berlin, Heidelberg: Springer; 1995: 99-112 DOI: 10.1007/978-3-642-85434-7_8
    CrossrefGoogle Scholar
  • 31 Kennelly E, Baggett S, Nuntanakorn P. et al. Analysis of thirteen populations of black cohosh for formononetin. Phytomedicine 2002; 9: 461-467
    CrossrefPubMedGoogle Scholar
  • 32 Wuttke W, Gorkow C, Seidlová-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women. Menopause 2006; 13: 185-196
    CrossrefPubMedGoogle Scholar
  • 33 Mohapatra S, Iqubal A. et al. Benefits of black cohosh (Cimicifuga racemosa) for women health: An up-close and in-depth review. Pharmaceuticals (Basel) 2022; 15: 278
    CrossrefPubMedGoogle Scholar